Source Bioscience Company News

Epic Code:
Sub Sector:
Market Cap:

Pharmaceuticals & Biotechnology
UK Main Market
17.7829571976 GBPm

Data as of 10:00 23/09/2009. Check director details and other company announcments at Source Bioscience Website .

RNS News for Source Bioscience

Regulatory News Service : RNS provides a service that enables local or international listed companies to meet company news reporting obligations in UK, Europe and US - international filings use different processes: Provides investors & professionals equal access to new company information as it is released. For further details of RNS news see London Stock Exchange website.

Latest Source Bioscience News

Arix Bioscience PLC (ARIX) Insider Acquires £57712.96 in Stock
Stock Observer - 12 hours ago
Arix Bioscience PLC logo Arix Bioscience PLC (LON:ARIX) insider Jonathan Peacock purchased 28,016 shares of Arix Bioscience PLC stock in a transaction dated Friday, June 2nd. The shares were purchased at an average price of GBX 206 ($2.62) per ...

06/26/2017 02:07 PM

Behind big pharma's race to develop the next wave of cancer therapy - Jun 25, 2017
Pharmaceutical companies are betting big on a new wave of innovative cancer therapies they believe will be more effective than existing treatments and move them a big step closer to finding a cure for the disease.

06/25/2017 09:16 PM

Arix Bioscience co-leads $45 million Series B investment round for Harpoon ...
GlobeNewswire (press release) - May 25, 2017
LONDON, 25 May, 2017: Arix Bioscience plc (LSE: ARIX) ("Arix Bioscience" or "the Company"), a global healthcare and life science company supporting medical innovation, today announced that Harpoon Therapeutics, a new Arix Group Business, has closed ...
Harpoon Therapeutics Announces Completion of $45M Series B Financing - (press release)

05/25/2017 12:03 PM

Biotech giant backed by Neil Woodford confirms £100m London float
City A.M. - Feb 2, 2017
UK healthcare giant Arix Bioscience, backed by biotech entrepreneur Sir Chris Evans and star investor Neil Woodford, is hoping to raise £100m in a stock market float in London.

02/02/2017 12:50 PM

Roka Bioscience Announces Transition of CEO Role from Paul Thomas to Mary Duseau
PR Newswire (press release) - Jan 17, 2017
Mary Duseau, 51, has served as Senior Vice President, Chief Commercial Officer of Roka Bioscience since February 2015. From October 2012 until January 2015, Ms. Duseau served as Global Sales Director and on the board at Andor Technology plc ...

01/17/2017 09:18 PM

Investors make Source BioScience takeover offer
Insider Media - Jul 29, 2016
The board of Nottingham laboratory services and products provider Source BioScience has accepted a takeover bid which values the business at almost £63m.

07/29/2016 10:58 AM